Document is current
Any future updates will be listed below
-
Authors
Rank, Nina https://orcid.org/0000-0002-5984-4836
Pfahringer, Boris https://orcid.org/0000-0002-7921-8103
Kempfert, Jörg
Stamm, Christof
Kühne, Titus https://orcid.org/0000-0003-1631-4824
Schoenrath, Felix
Falk, Volkmar https://orcid.org/0000-0002-7911-8620
Eickhoff, Carsten https://orcid.org/0000-0001-9895-4061
Meyer, Alexander https://orcid.org/0000-0002-6944-2478
- License Information
-
More Information
Article History
Received: 10 February 2020
Accepted: 17 September 2020
First Online: 26 October 2020
Competing interests
: A.M. declares the receipt of consulting and lecturing fees from Medtronic GmbH and Edwards Lifesciences Services GmbH, and consulting fees from Pfizer. C.E. declares ownership of shares in codiag AG. F.S. declares the receipt of honoraria, consultancy fees or travel support from Medtronic GmbH, Biotronik SE & Co., Abbott GmbH & Co. KG, Sanofi S.A., Cardiorentis AG, Novartis Pharma GmbH. J.K. declares the receipt of lecturing fees from, Boston Scientific, LSI Solutions, Edwards, Medtronic, Abbott, Ascyrus Medical GmbH. V.F. declares (institutional) financial activities with Medtronic, Biotronik, Abbott, Boston, Edwards, Berlin Heart, Novartis, Jotec, Zurich Heart in relation to Educational Grants, honoraria, consultancy, research & study funds, fees for travel support. All other authors declare no competing interests.
